|
|
|
Sunday, March 21, 2010 — 7:30 PM, Salon 2
|
- Breast Pathology Practice in the Era of Molecular and Personalized Therapy of Breast Cancer
|
|
Moderators:
|
Juan P. Palazzo, Jefferson University, Philadelphia, PA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click any blue title below to display and print the handout for individual lecture(s):
| 7:30 | Biology-Driven Selection of Optimal Systemic Therapy for Primary Breast Cancer - Gabriel N. Hortobagyi, The University of Texas, MD Anderson Cancer Center, Houston, TX |
| 8:00 | Pathologic Response Following Neoadjuvant Chemotherapy as an Outcome for Clinical and Translational Research - W. Fraser Symmans, The University of Texas, MD Anderson Cancer Center, Houston, TX |
| 8:30 | Modern Classification of Breast Cancer-Should We Stick with Morphology or Convert to Molecular Profiles? - Ian O. Ellis, City Hospital NHS Trust, England |
|
During our business meeting that takes place at the USCAP meeting all the officers of the society discuss at length the possible topics. We also consider the feedback received from members of the Society as well as participants in the Companion meetings. The objectives of the program are always to advance the understanding of breast pathology and to present the most updated and useful information for the participants and pathologists attending the meeting.
|
|
|
|
